RBD class 1 and 2 antibody epitopes elicit around 70% neutralizing capacity against SARS-CoV-2 virus following boosting with inactivated virus vaccine
- Resource Type
- Short Communication
- Source
- In
Vaccine 18 December 2023 41(52):7641-7646 - Subject
- Language
- ISSN
- 0264-410X